A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Incyte Corporation

Summary

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Age ≥ 18 years inclusive at the time of signing the ICF * Allogeneic SCT 90 to 180 days prior to enrollment * Able to comprehend and willing to provide informed consent * Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel Exclusion Criteria: * There are no exclusion criteria for this study

Interventions

Other
Non-Interventional
This is an observational study

Locations (32)

University of Alabama Birmingham
Birmingham, Alabama
Mayo Clinic Arizona
Phoenix, Arizona
City of Hope
Duarte, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
University of Colorado
Aurora, Colorado
Mayo Clinic Jacksonville
Jacksonville, Florida